Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.042 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |